CovidChloroV1, Main, Corpus, bibRecord, 001671

Chloroquine and hydroxychloroquine during pregnancy: What do we know?

Identifieur interne : 001671 ( Main/Corpus ); précédent : 001670; suivant : 001672

Chloroquine and hydroxychloroquine during pregnancy: What do we know?

Auteurs : Isabelle Lacroix ; Justine Bénévent ; Christine Damase-Michel

Source :

Therapie [ 1958-5578 ]

RBID : pubmed:32418732

English descriptors

KwdEn :
- COVID-19 (MeSH), Chloroquine (administration & dosage), Chloroquine (adverse effects), Coronavirus Infections (drug therapy), Female (MeSH), Humans (MeSH), Hydroxychloroquine (administration & dosage), Hydroxychloroquine (adverse effects), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pregnancy (MeSH), Pregnancy Complications, Infectious (drug therapy), Pregnancy Complications, Infectious (virology).
MESH :
- chemical , administration & dosage : Chloroquine, Hydroxychloroquine.
- chemical , adverse effects : Chloroquine, Hydroxychloroquine.
- drug therapy : Coronavirus Infections, Pneumonia, Viral, Pregnancy Complications, Infectious.
- virology : Pregnancy Complications, Infectious.
- COVID-19, Female, Humans, Pandemics, Pregnancy.

DOI: 10.1016/j.therap.2020.05.004
PubMed: 32418732
PubMed Central: PMC7211694

Links to Exploration step

pubmed:32418732

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Chloroquine and hydroxychloroquine during pregnancy: What do we know?</title>
<author><name sortKey="Lacroix, Isabelle" sort="Lacroix, Isabelle" uniqKey="Lacroix I" first="Isabelle" last="Lacroix">Isabelle Lacroix</name>
<affiliation><nlm:affiliation>Unité « Médicaments, grossesse et allaitement », service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine, Inserm 1027, 37, allées Jules-Guesde, 31000 Toulouse, France. Electronic address: isabelle.lacroix@univ-tlse3.fr.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Benevent, Justine" sort="Benevent, Justine" uniqKey="Benevent J" first="Justine" last="Bénévent">Justine Bénévent</name>
<affiliation><nlm:affiliation>Unité « Médicaments, grossesse et allaitement », service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine, Inserm 1027, 37, allées Jules-Guesde, 31000 Toulouse, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Damase Michel, Christine" sort="Damase Michel, Christine" uniqKey="Damase Michel C" first="Christine" last="Damase-Michel">Christine Damase-Michel</name>
<affiliation><nlm:affiliation>Unité « Médicaments, grossesse et allaitement », service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine, Inserm 1027, 37, allées Jules-Guesde, 31000 Toulouse, France.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020 Jul - Aug</date>
<idno type="RBID">pubmed:32418732</idno>
<idno type="pmid">32418732</idno>
<idno type="doi">10.1016/j.therap.2020.05.004</idno>
<idno type="pmc">PMC7211694</idno>
<idno type="wicri:Area/Main/Corpus">001671</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001671</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Chloroquine and hydroxychloroquine during pregnancy: What do we know?</title>
<author><name sortKey="Lacroix, Isabelle" sort="Lacroix, Isabelle" uniqKey="Lacroix I" first="Isabelle" last="Lacroix">Isabelle Lacroix</name>
<affiliation><nlm:affiliation>Unité « Médicaments, grossesse et allaitement », service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine, Inserm 1027, 37, allées Jules-Guesde, 31000 Toulouse, France. Electronic address: isabelle.lacroix@univ-tlse3.fr.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Benevent, Justine" sort="Benevent, Justine" uniqKey="Benevent J" first="Justine" last="Bénévent">Justine Bénévent</name>
<affiliation><nlm:affiliation>Unité « Médicaments, grossesse et allaitement », service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine, Inserm 1027, 37, allées Jules-Guesde, 31000 Toulouse, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Damase Michel, Christine" sort="Damase Michel, Christine" uniqKey="Damase Michel C" first="Christine" last="Damase-Michel">Christine Damase-Michel</name>
<affiliation><nlm:affiliation>Unité « Médicaments, grossesse et allaitement », service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine, Inserm 1027, 37, allées Jules-Guesde, 31000 Toulouse, France.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Therapie</title>
<idno type="eISSN">1958-5578</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>COVID-19 (MeSH)</term>
<term>Chloroquine (administration & dosage)</term>
<term>Chloroquine (adverse effects)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (administration & dosage)</term>
<term>Hydroxychloroquine (adverse effects)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pregnancy (MeSH)</term>
<term>Pregnancy Complications, Infectious (drug therapy)</term>
<term>Pregnancy Complications, Infectious (virology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Pregnancy Complications, Infectious</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Pregnancy Complications, Infectious</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Female</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Pregnancy</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32418732</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1958-5578</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>75</Volume>
<Issue>4</Issue>
<PubDate><MedlineDate>2020 Jul - Aug</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Therapie</Title>
<ISOAbbreviation>Therapie</ISOAbbreviation>
</Journal>
<ArticleTitle>Chloroquine and hydroxychloroquine during pregnancy: What do we know?</ArticleTitle>
<Pagination><MedlinePgn>384-385</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0040-5957(20)30093-7</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.therap.2020.05.004</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lacroix</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Unité « Médicaments, grossesse et allaitement », service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine, Inserm 1027, 37, allées Jules-Guesde, 31000 Toulouse, France. Electronic address: isabelle.lacroix@univ-tlse3.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bénévent</LastName>
<ForeName>Justine</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Unité « Médicaments, grossesse et allaitement », service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine, Inserm 1027, 37, allées Jules-Guesde, 31000 Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Damase-Michel</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Unité « Médicaments, grossesse et allaitement », service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine, Inserm 1027, 37, allées Jules-Guesde, 31000 Toulouse, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Therapie</MedlineTA>
<NlmUniqueID>0420544</NlmUniqueID>
<ISSNLinking>0040-5957</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Chloroquine</Keyword>
<Keyword MajorTopicYN="Y">Covid-19</Keyword>
<Keyword MajorTopicYN="Y">Hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="Y">Pregnancy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>05</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32418732</ArticleId>
<ArticleId IdType="pii">S0040-5957(20)30093-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.therap.2020.05.004</ArticleId>
<ArticleId IdType="pmc">PMC7211694</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Can J Ophthalmol. 2011 Jun;46(3):289-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21784221</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Clin Pharmacol. 2016 May;81(5):835-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26700396</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Joint Bone Spine. 2018 Dec;85(6):663-668</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29631068</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Rheumatol. 2011 Dec;38(12):2504-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22002012</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Therapie. 2013 Jan-Feb;68(1):43-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23484660</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Rheumatol. 2018 May;30(3):249-255</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29517495</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Therapie. 2019 Apr;74(2):289-300</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30797568</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trans R Soc Trop Med Hyg. 2002 Mar-Apr;96(2):180-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12055810</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2005 Jan 1;191(1):109-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15593011</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br Med J (Clin Res Ed). 1985 May 18;290(6480):1466-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3922534</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001671 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001671 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32418732
   |texte=   Chloroquine and hydroxychloroquine during pregnancy: What do we know?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32418732" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Chloroquine and hydroxychloroquine during pregnancy: What do we know?

Chloroquine and hydroxychloroquine during pregnancy: What do we know?

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki